Development and pre-clinical evaluation of Newcastle disease virus-vectored SARS-CoV-2 intranasal vaccine candidate
M. Fernandez-Diaz, K. Calderon, A. Rojas-Neyra, V. N. Vakharia, R. Choque-Guevara, A. Montalvan, A. Poma-Acevedo, D. Rios-Matos, A. Agurto-Arteaga, M. D. G. Cauti-Mendoza, N. Perez-Martinez, G. Isasi-Rivas, L. Tataje-Lavanda, M. Palomino, H. Bailon, , Salguedo-Bohorqu
This paper develops and evaluates an NDV-vectored SARS-CoV-2 intranasal vaccine candidate, showing safety, immunogenicity, and efficacy in animal models.
bioRxiv · Mar 7, 2021 · PreprintImmunology